Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States
- Resource Type
- Article
- Source
- In
Value in Health September 2015 18(6):876-883 - Subject
- Language
- ISSN
- 1098-3015